Delivery Order SPE2DB20D1050-SPE2DB24FH65W
- Not listed
- This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of TRUMENBA 120 MCG/0.5 ML VACCIN 0.5ML. The contract has a ceiling value of $1,062.52 and is a Firm Fixed Price type contract. The place of performance is Conshohocken, Pennsylvania. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRUMENBA 120MCG 10S, a vaccine product. The contract has a ceiling value of $1,062.52 and a period of performance through June 30, 2025. This award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRUMENBA 120 MCG/0.5 ML VACCIN 0.5ML, a vaccine product. The contract has a ceiling value of $1,222.33 and runs through March 5, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,062.52 contract is for the supply of 120 mcg/0.5 ml doses of the Trumenba vaccine, with a performance period ending on May 8, 2025. The award is not set-aside and represents an open competition. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the provision of 120 mcg/0.5 ml doses of the TRUMENBA vaccine, a total ceiling value of $2,125.04. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide TRUMENBA 120 MCG/0.5 ML VACCIN 0.5ML. The contract has a ceiling value of $2,125.04 and is a firm fixed price delivery order with a completion date of May 30, 2025. The contract is not set-aside and is an open competition award. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRUMENBA 120MCG 10S, a pharmaceutical product, with a ceiling value of $2,125.04 and a completion date of July 3, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Trumenba 120 micrograms/0.5 milliliter vaccine in 0.5 milliliter units, with a ceiling value of $1,749.30 and firm fixed pricing. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The performance location is...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,152.72 firm fixed-price delivery order is for the supply of TRUMENBA 120 MCG/0.5 ML VACCINE 0.5ML, a vaccine product. The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- The Defense Logistics Agency awarded a delivery order valued at $1,062.52 to AmerisourceBergen Drug Corp for the supply of Trumenba (meningococcal vaccine B) 120 mcg/0.5 mL doses on August 14, 2025, with completion targeted for August 15, 2025. The order represents a firm fixed price, competitively awarded delivery against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global pharmaceutical support vehicle...
- SPE2DB20D1050Indefinite Delivery Contract
- SPE2DB20D1050-SPE2DB24FH65WDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of TRUMENBA 120 MCG/0.5 ML VACCIN 0.5ML. The firm-fixed-price contract, valued at $4,950.60, has a performance period through May 9, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract is awarded on a full and open competition basis without any set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 5/8/24 |